A COVID Vaccine And Stocks

A COVID Vaccine And Stocks

over 3 years ago2 mins

With the fabled coronavirus vaccine starting to look like a reality, we looked into whether it’ll actually make stocks feel better 💉

What does this mean?

The pandemic – and this is the kind of astute analysis you come to Finimize for – isn’t over yet: that much is clear from reports of rising coronavirus cases in Europe and the UK, and from the Federal Reserve’s calls for the US government to support the economic recovery with more spending 🦠 But investors are still betting a vaccine will be approved by the end of this year or early next, and that parts of the global economy will be back at pre-COVID levels by the end of 2021.

Source: CNBC
Source: CNBC

A vaccine, economists estimate, would boost US economic growth by 3% and the eurozone’s by 2% 📈 That’d be great for stocks overall, but it’d be particularly good for stocks in a few specific industries…

Why should I care?

So-called “growth” stocks – whose earnings are expected to rise rapidly – and “defensive” stocks – whose earnings are relatively stable no matter what – have held up pretty well during the pandemic. But once there’s an economy-boosting vaccine, investors are likely to switch to cheap-looking “value” stocks, as well as to “cyclicals”, whose fortunes tend to rise and fall with economic growth 📊 Then again, there’s no pressure to chase those short-term trends: stocks geared toward themes like digitization and renewable energy will likely beat everything else in the long run.

Now there’s more confidence in the timing of a coronavirus vaccine, investors’ focus is increasingly turning to who will be behind it: nine candidates of the original 170 are in the final stages of testing, with frontrunners including Britain’s AstraZeneca and America’s Moderna and Pfizer 🏃‍♂️ Of course, it’s anyone’s guess which treatment will cross the finish line first – let alone how much it’ll ultimately earn the company.

Source: The Guardian
Source: The Guardian
Finimize

BECOME A SMARTER INVESTOR

All the daily investing news and insights you need in one subscription.

Disclaimer: These articles are provided for information purposes only. Occasionally, an opinion about whether to buy or sell a specific investment may be provided. The content is not intended to be a personal recommendation to buy or sell any financial instrument or product, or to adopt any investment strategy as it is not provided based on an assessment of your investing knowledge and experience, your financial situation or your investment objectives. The value of your investments, and the income derived from them, may go down as well as up. You may not get back all the money that you invest. The investments referred to in this article may not be suitable for all investors, and if in doubt, an investor should seek advice from a qualified investment advisor.

/3 Your free quarterly content is about to expire. Uncover the biggest trends and opportunities. Subscribe now for 50%. Cancel anytime.

Finimize
© Finimize Ltd. 2023. 10328011. 280 Bishopsgate, London, EC2M 4AG